Publicaciones (352) Publicaciones de JOSE VICENTE CASTELL RIPOLL

2024

  1. Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study

    Microchemical Journal, Vol. 198

  2. Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data

    Analytica chimica acta, Vol. 1286, pp. 342052

  3. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  4. Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer

    Applied Spectroscopy Reviews, Vol. 59, Núm. 4, pp. 578-599

  5. Protectiveness of NAM-based hazard assessment - which testing scope is required?

    ALTEX, Vol. 41, Núm. 2, pp. 302-319

  6. Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders

    Alternatives to Laboratory Animals, Vol. 52, Núm. 2, pp. 117-131

  7. Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches

    Toxicology, Vol. 504

2023

  1. A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies

    Stem Cell Research and Therapy, Vol. 14, Núm. 1

  2. Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds

    Stem cells (Dayton, Ohio), Vol. 41, Núm. 11, pp. 1076-1088

  3. Comparing the direct assessment of steatosis in liver explants with mid- and near-infrared vibrational spectroscopy, prior to organ transplantation

    The Analyst, Vol. 148, Núm. 17, pp. 3986-3991

  4. Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference

    Analyst, Vol. 148, Núm. 13, pp. 3097-3106

  5. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients

    Nutrients, Vol. 15, Núm. 14

  6. Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved

    Archives of Toxicology, Vol. 97, Núm. 6, pp. 1723-1738

  7. The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics

    Frontiers in Pharmacology, Vol. 14

2022

  1. A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes

    Journal of Proteome Research, Vol. 21, Núm. 3, pp. 702-712

  2. Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection

    Scientific Reports, Vol. 12, Núm. 1

  3. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay

    Toxicology Letters, Vol. 368, pp. 33-46

  4. Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen

    Antioxidants, Vol. 11, Núm. 5

  5. Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate “Diseased” Hepatocytes for Accurate Diagnosis

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  6. Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds

    Scientific Data